IP Library Granted Patent US 10,472,384
Granted Patent B2
US 10,472,384 · App. 15/990,135 · Granted Nov 12, 2019

Methods for the purification of deoxycholic acid

Inventors: Robert M. Moriarty (Michiana Shores, IN); Achampeta Rathan Prasad (Hyderabad, IN); John Gregory Reid (Groton, MA); Roy A. Swaringen, Jr. (Durham, NC)
Assignee: ALLERGAN SALES, LLC
C07J9/005A61K31/575C07J1/0011C07J5/0053C07J9/00C07J13/007C07J41/0061Y02P20/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,472,384
App. No.
15/990,135
Granted
Nov 12, 2019
Kind
B2
Abstract

Synthetic methods for preparing deoxycholic acid and intermediates thereof, high purity synthetic deoxycholic acid, compositions and methods of use are provided. Also, provided are processes for the synthesis of 12-keto or 12-α-hydroxysteroids from Δ-9,11-ene, 11-keto or 11-hydroxy-β-steroids. This invention is also directed to novel compounds prepared during the synthesis. This invention is also directed to the synthesis of deoxycholic acid starting from hydrocortisone.

Claims (18)

1. A process for preparing a compound of formula 1:

the process comprising contacting Δ-9,11-ene compound 4:

with an alkylhydroperoxide of the formula (R 3 )(R 4 )(R 5 )C—O—OH in the presence of a co-oxidant,

wherein

Pg is a hydroxyl protecting group,

R is hydrogen, hydroxyl, or —OPg, R 1 is the 17-side chain of a bile acid selected from the group consisting of cholic acid, deoxycholic acid, taurocholic acid, and glycocholic acid, wherein the carboxyl functionality of said side chain is optionally esterified with a C 1 -C 6 alkyl group, and R 2 is hydrogen, or R 1 and R 2 together with the carbon atom attached thereto form a keto or a keto protecting group, and

each of R 3 , R 4 and R 5 is independently C 1 -C 3 alkyl.

2. The process of claim 1 , wherein compound 4 is contacted with more than one equivalent of tert-butyl hydroperoxide and in the presence of CuI.

3. The process of claim 1 , wherein the co-oxidant is selected from the group consisting of aqueous sodium hypochlorite, palladium on carbon, Pd(OCOCF 3 ) 2 , Pd(OAc) 2 and CuI.

4. The process of claim 1 , wherein the compound of formula 1 is selected from the group consisting of compounds 42, 43, 44, 45 and 46:

5. The process of claim 1 , wherein R 1 is selected from the group consisting of

wherein R 6 is lower alkyl and the wavy line

represents the point of connection to the 17-position of steroidal scaffold.

6. The process of claim 1 , wherein R 1 and R 2 together with the carbon atom attached thereto form a keto group.

7. The process of claim 1 , wherein R 1 and R 2 together with the carbon atom attached thereto form:

wherein n is 1, 2, or 3 and the wavy line

represents the point of connection to the rest of the molecule.

8. The process of claim 1 , wherein R is hydrogen.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Sep 20, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 050439/0024 →
CHANGE OF NAME Recorded Sep 18, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 050427/0853 →
Priority Claims (1)
GB 1008726.0 · May 25, 2010 · national
Continuity (8)
Continuation 15603290 · May 23, 2017
Continuation 14532940 · Nov 4, 2014
Continuation 13140421
Provisional Application 61288132 · Dec 18, 2009
Provisional Application 61302007 · Feb 5, 2010
Provisional Application 61303816 · Feb 12, 2010
Provisional Application 61348686 · May 26, 2010
Related Publication 20190135855A1 · May 9, 2019